Trevi Therapeutics (TRVI) Change in Receivables (2018 - 2020)
Trevi Therapeutics' (TRVI) quarterly Change in Receivables came in at -$433000.0 in Q1 2020, down 1173.53% year-on-year from $40334.2 in Q2 2019, and down 221.97% quarter-over-quarter from $355000.0 in Q4 2019.
Trevi Therapeutics (TRVI) Change in Receivables (2018 - 2020) Analysis & Trends
Trevi Therapeutics' Change in Receivables history runs 3 years deep, the most recent figure standing at -$433000.0 for Q1 2020.
- On a quarterly basis, Change in Receivables fell 1173.53% year-over-year to -$433000.0 in Q1 2020; TTM through Mar 2020 was -$25000.0, a 130.12% decrease from a year earlier, with the FY2019 full-year figure at $374000.0, up 177.04% from the prior year.
- Change in Receivables eased to -$433000.0 in Q1 2020 per TRVI's latest filing, from $355000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $355000.0 in Q4 2019 and bottomed at -$433000.0 in Q1 2020.
- The 3-year median for Change in Receivables is $20000.0 (2018), against an average of $8444.4.
- Across the five-year window, Change in Receivables surged 446.15% in 2019 and tumbled 1173.53% in 2020, its largest moves.
- Year by year, Change in Receivables stood at $65000.0 in 2018, then jumped by 446.15% to $355000.0 in 2019, then sank by 221.97% to -$433000.0 in 2020.
- Per Business Quant, the three latest TRVI Change in Receivables figures stand at -$433000.0 (Q1 2020), $355000.0 (Q4 2019), and -$48000.0 (Q3 2019).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Trevi Therapeutics | 2.50 Bn | 2.50 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -433,000.00 |
| Mar 31, 2020 | -433,000.00 |
| Dec 31, 2019 | 355,000.00 |
| Dec 31, 2019 | 355,000.00 |
| Sep 30, 2019 | -48,000.00 |
| Sep 30, 2019 | -48,000.00 |
| Jun 30, 2019 | 101,000.00 |
| Jun 30, 2019 | 101,000.00 |
| Mar 31, 2019 | -34,000.00 |
| Mar 31, 2019 | -34,000.00 |
| Dec 31, 2018 | 65,000.00 |
| Dec 31, 2018 | 65,000.00 |
| Sep 30, 2018 | 32,000.00 |
| Sep 30, 2018 | 32,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Mar 31, 2018 | 18,000.00 |
| Mar 31, 2018 | 18,000.00 |